OncoBeta Announces Groundbreaking 12-Month Results for Rhenium-SCT in Non-Melanoma Skin Cancer OncoBeta's latest study reveals impressive 12-month results from its Phase IV trial for non-melanoma skin cancer, showcasing majority treatment success and patient satisfaction.

OncoBeta Announces Groundbreaking 12-Month Results for Rhenium-SCT in Non-Melanoma Skin Cancer #Germany #NMSC #OncoBeta #Rhenium-SCT #Garching